Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in MRNA — Moderna, Inc.

CIK 1595888 NEW YORK, NY
Back to MRNA Full portfolio

Position in MRNA

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$2,004,719
+$1,349,217 QoQ
Shares Held
39,463
+77.5% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Mar 31, 2026
CallValue
$142,067,280
CallShares
2,796,600
PutValue
$229,489,000
PutShares
4,517,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names. MRNA ranks #85 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 1,757,672 $130,524,721
2 RPRX
Royalty Pharma plc
 2,400,382 $115,146,324
3 TGTX
Tg Therapeutics, Inc.
 2,041,669 $67,824,242
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 122,946 $54,900,305
5 HALO
Halozyme Therapeutics, Inc.
 831,707 $53,753,223
6 EXEL
Exelixis, Inc.
 1,087,030 $46,622,715
7 JAZZ
Jazz Pharmaceuticals plc
 223,615 $42,274,415
8 BNTX
BioNTech SE
 336,757 $29,930,962

All Filings in MRNA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $142,067,280 2,796,600
2026-03-31 $2,004,719 39,463
2026-03-31 $229,489,000 4,517,500
2025-12-31 $94,536,093 3,205,700
2025-12-31 $655,502 22,228
2025-12-31 $128,098,662 4,343,800
2025-09-30 $66,920,364 2,590,800
2025-09-30 $35,624,528 1,379,192
2025-09-30 $129,695,013 5,021,100
2025-06-30 $104,338,729 3,781,759
2025-06-30 $82,083,009 2,975,100
2025-06-30 $118,499,050 4,295,000
2025-03-31 $101,720,848 3,588,037
2025-03-31 $93,149,595 3,285,700
2025-03-31 $95,981,760 3,385,600
2024-12-31 $150,314,193 3,615,060
2024-12-31 $17,313,912 416,400
2024-12-31 $89,031,096 2,141,200
2024-09-30 $60,160,366 900,200
2024-09-30 $42,114,860 630,179
2024-09-30 $72,670,942 1,087,400
2024-06-30 $156,096,756 1,314,499
2024-03-31 $52,596,949 493,590
2023-12-31 $69,218,988 696,018
2023-09-30 $37,338,095 361,488
2023-06-30 $38,003,984 312,790
2023-03-31 $162,332,524 1,056,990
2022-12-31 $106,340,247 592,029
2022-09-30 $59,933,828 506,840
2022-06-30 $56,539,171 395,794
2022-03-31 $110,821,576 643,339
2022-03-31 $359,248,230 2,085,500
2022-03-31 $322,091,748 1,869,800
2021-12-31 $340,300,181 1,339,870
2021-12-31 $807,986,574 3,181,300
2021-12-31 $941,326,074 3,706,300
2021-09-30 $860,970,306 2,237,100
2021-09-30 $1,134,259,392 2,947,200
2021-09-30 $177,198,010 460,422
2021-06-30 $459,879,358 1,957,100
2021-06-30 $295,839,820 1,259,000
2021-06-30 $210,405,790 895,420
2021-03-31 $150,160,365 1,146,700
2021-03-31 $256,858,425 1,961,500
2021-03-31 $34,241,852 261,488
2020-12-31 $221,110,755 2,116,500
2020-12-31 $128,842,851 1,233,300
2020-12-31 $81,859,243 783,567
2020-09-30 $95,505,425 1,349,900
2020-09-30 $80,195,125 1,133,500

Report a Problem

Category
Description
Email (optional, for follow-up)